ArticleTrials2024

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial.

Xinlun Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.